HK Stock Market Move | BILIBILI-W (09626) gained nearly 7% in the after-hours market. AI technology improves the efficiency of marketing material production and the effectiveness of advertising placement.
Bilibili-W (09626) rose nearly 7% in the final trading session, as of the time of writing, it rose by 6.62%, closing at HK$238.2, with a trading volume of HK$1.148 billion.
BILIBILI-W (09626) rose nearly 7% at the end of the session, rising 6.62% as of the time of publication, to HK$238.2, with a trading volume of HK$11.48 billion.
Fulai released a research report stating that for Bilibili's performance preview for the fourth quarter of 2025, it is expected that the quarterly revenue and non-GAAP operating profit will meet the bank's forecasts, with total revenue increasing by approximately 5% to reach RMB 8.1 billion. The bank pointed out that in terms of gaming, "Escape from Tarkov" has achieved success, with a gaming strategy focusing on leading positions in vertical categories, long-term product operation, and the younger generation. According to the bank's 2026 outlook report, AI is expected to become a key area of focus, and the entertainment industry is favored for its defensive nature.
China Great Wall released a research report stating that Bilibili's AI-driven content production has contributed to increasing platform user numbers to reach record highs, with a stable base of differentiated traffic. The company's AI technology has improved marketing material production efficiency and advertising placement effectiveness, with AI video materials accounting for over 60% of consumption, and intelligent advertising placement accounting for over 45%. Overall distribution efficiency has increased by over 10%. In addition, "Three Kingdoms: Rule the World" has maintained steady performance, with attention to the company's progress in new games.
Related Articles

STANCHART (02888) spent 9.8582 million pounds to repurchase 549,000 shares on January 9th.

HAITONG UT (01905) plans to issue corporate bonds not exceeding 1 billion yuan.

Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for the issuance of H shares, and the materials have been accepted by the China Securities Regulatory Commission.
STANCHART (02888) spent 9.8582 million pounds to repurchase 549,000 shares on January 9th.

HAITONG UT (01905) plans to issue corporate bonds not exceeding 1 billion yuan.

Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for the issuance of H shares, and the materials have been accepted by the China Securities Regulatory Commission.

RECOMMEND

Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026

Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026

“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026


